tiprankstipranks
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874)
HKEX:0874

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Ownership - Who Owns Guangzhou Baiyunshan Pharmaceutical Holdings Company?

0 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Ownership Overview

0.00%4.21%2.02%93.76%
0.00%
Insiders
2.02% Other Institutional Investors
93.76% Public Companies and
Individual Investors
The ownership structure of Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) stock is a mix of institutional, retail and individual investors. Approximately 6.24% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 93.76% is owned by Public Companies and Individual Investors.
The ownership structure of Guangzhou Baiyunshan Pharmaceutical Holdings Company (HK:0874) stock is a mix of institutional, retail and individual investors. Approximately 6.24% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 93.76% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,814,445Institution1.73%10,161,681
3,296,445Institution1.50%8,781,729
3,131,267Institution1.42%8,341,695
1,108,000Institution0.50%2,951,712
1,056,000Institution0.48%2,813,184
248,556Institution0.11%662,153
212,786Institution0.10%566,862
130,000Institution0.06%346,320
114,000Institution0.05%303,696
108,000Institution0.05%287,712

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,296,445Institution1.50%8,781,729
3,131,267Institution1.42%8,341,695
1,108,000Institution0.50%2,951,712
1,056,000Institution0.48%2,813,184
212,786Institution0.10%566,862
130,000Institution0.06%346,320
114,000Institution0.05%303,696
102,000Institution0.05%271,728
46,000Institution0.02%122,544
44,000Institution0.02%117,216

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,597,825Institution1.18%7,408,906
502,620Institution0.23%1,433,453
248,556Institution0.11%657,412
130,000Institution0.06%370,755
70,000Institution0.03%185,485
62,000Institution0.03%163,985
62,000Institution0.03%163,985
46,000Institution0.02%121,667
42,000Institution0.02%111,291
36,000Institution0.02%102,386

FAQ

Who Owns Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874)?
According to the latest TipRanks data, approximately 2.02% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 93.76% is held by retail investors.
    What percentage of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 2.02% of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874) stock is held by institutional investors.
      What percentage of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874) stock is held by retail investors?
      According to the latest TipRanks data, approximately 93.76% of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874) stock is held by retail investors.
        Who owns the most shares of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874)?
        Vanguard owns the most shares of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis